Clinical Application of Induced Pluripotent Stem Cells in Muscular Dystrophy

At the recent 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, March 19-22, in Dallas, Texas, Rita Perlingeiro, PhD, recently presented a talk on the potential of using iPS cells in the treatment of muscular dystrophy. The rest of the session focused on the use of patient-specific iPS cells to model neuromuscular diseases, with the goal of understanding disease pathogenesis and treatment development. Also, the session emphasized the expansion of bioengineering approaches for skeletal muscle modeling. In an interview with CGTLive®, a sister publication to NeurologyLive®, Perlingeiro, the Lillehei professor in stem cell and regenerative cardiovascular medicine, department of medicine, University of Minnesota, provided an overview of some of the main highlights addressed in the session. She also spoke about the challenges and unmet needs in the field starting to gain attention, as well as the potential of iPS in regenerative medicine. (https://www.neurologylive.com/view/clinical-application-induced-pluripotent-stem-cells-muscular-dystrophy-rita-perlingeiro) More MDA Content: -https://www.neurologylive.com/conferences/mda